0000905148-24-001113.txt : 20240405 0000905148-24-001113.hdr.sgml : 20240405 20240405174835 ACCESSION NUMBER: 0000905148-24-001113 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240403 FILED AS OF DATE: 20240405 DATE AS OF CHANGE: 20240405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reinhart Harald CENTRAL INDEX KEY: 0001835824 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38205 FILM NUMBER: 24827654 MAIL ADDRESS: STREET 1: 4560 JINKE ROAD, BLDG. 1, FOURTH FLOOR STREET 2: PUDONG CITY: SHANGHAI STATE: F4 ZIP: 201210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zai Lab Ltd CENTRAL INDEX KEY: 0001704292 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4560 JINKE ROAD STREET 2: BLDG. 1, 4F, PUDONG CITY: SHANGHAI STATE: F4 ZIP: 201210 BUSINESS PHONE: 862161632588 MAIL ADDRESS: STREET 1: 4560 JINKE ROAD STREET 2: BLDG. 1, 4F, PUDONG CITY: SHANGHAI STATE: F4 ZIP: 201210 4 1 form4.xml X0508 4 2024-04-03 0001704292 Zai Lab Ltd ZLAB 0001835824 Reinhart Harald C/O ZAI LAB LIMITED 314 MAIN STREET, 4TH FLOOR, SUITE 100 CAMBRIDGE MA 02142 true See Remarks false American Depositary Shares 2024-04-03 4 M 0 5270 15.9 A 53905 D American Depositary Shares 2024-04-04 4 S 0 2105 15.673 D 51800 D Restricted Share Units 2024-04-03 4 M 0 5270 0 D American Depositary Shares 5270 15811 D Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs. ADSs acquired upon vesting of Restricted Share Units ("RSUs"). These ADSs were sold automatically to cover taxes upon vesting of RSUs. Each RSU represents a contingent right to receive one ADS. The RSUs vest in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting. President and Head of Global Development for Neuroscience, Autoimmune and Infectious Diseases /s/ Bruce Blefeld, Attorney-in-Fact 2024-04-05